COVID-19

Vanderbilt, AstraZeneca collaborate on new COVID-19 antibody research

After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio.

Remdesivir helps reduce COVID-19 recovery time: study

The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.

Employees working from home bring value, safety to VUMC

As of early May, an average of 8,000 VUMC employees were working remotely each day, equaling more than 25% of VUMC’s total workforce.

Bereavement calls helping to aid grieving families

There has been nothing normal about the COVID-19 pandemic, and grieving the loss of a life at a time when families have been unable to gather beside a bedside to say goodbye, or to even hold a traditional funeral, has been one of the worst consequences of this health crisis’s uncharted territory.

Kathryn Miller demonstrates saying

Children’s Hospital experts say well-child visits remain as crucial as ever

Pediatricians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are stressing the continued importance of well-child visit for infants, children and adolescents, particularly during the COVID-19 pandemic.

Transcript: Special Message from Dr. Jeff Balser, President and CEO, on VUMC’s role in offering hope and healing

Dr. Jeff Balser talks about VUMC as a place of healing not only of illness, but of inequality and injustice, and how the Medical Center must comfort and provide hope and healing to those who are hurting, whatever the source of that pain.

1 26 27 28 29 30 40